| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 18 |
| 1 | METHYLPREDNISOLONE | 14 |
| 2 | PEMBROLIZUMAB | 14 |
| 3 | VEDOLIZUMAB | 14 |
| 4 | CEFUROXIME | 13 |
| 5 | CHOLESTYRAMINE | 13 |
| 6 | HYDROCORTISONE | 13 |
| 7 | IPILIMUMAB | 13 |
| 8 | LEVETIRACETAM | 13 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 2 | 0.0110 |
| 1 | CEFUROXIME | 13 | 0.0011 |
| 2 | CHOLESTYRAMINE | 13 | 0.0011 |
| 3 | TOFACITINIB CITRATE | 12 | 0.0009 |
| 4 | OCTREOTIDE ACETATE | 13 | 0.0004 |
| 5 | IPILIMUMAB | 13 | 0.0003 |
| 6 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 2 | 0.0003 |
| 7 | OXCARBAZEPINE | 4 | 0.0003 |
| 8 | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | 1 | 0.0002 |
| 9 | OLMESARTAN MEDOXOMIL | 8 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 9 | 0.0013 |
| 1 | Bile Acid Sequestrant [EPC] | 13 | 0.0011 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 13 | 0.0003 |
| 3 | Integrin Receptor Antagonist [EPC] | 14 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 14 | 0.0001 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 13 | 0.0001 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 12 | 0.0001 |
| 8 | Janus Kinase Inhibitor [EPC] | 12 | 0.0001 |
| 9 | Opioid Agonist [EPC] | 13 | 0.0000 |